Accelerate Genomic Medicine Innovations

Once you know what disease gene you want to target, you can very rapidly find the sequence of the molecule you want to use as the drug substance, and essentially print it out, go to a supplier or print it out on a machine. We work with the world’s leading drug developers to understand disease and create the therapeutics and vaccines that will define the future of medicine. PNI’s NanoAssemblr^® microfluidic instruments, GenVoy™ lipid nanoparticle delivery reagents, and Biopharmaceutical Services enable researchers to translate disease biology insights into non-viral genomic medicines.